COPD trials recruiting in Alabama

All COPD trials nationally

Cities in Alabama

Recruiting trials in Alabama

• A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
  NCT06283966 · Phase: Phase 3 · Ages: 40 Years to 80 Years · Sex: All (male and female) · Alabama: Athens, Cullman, Fairhope, Huntsville
• A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
  NCT07053423 · Phase: Phase 4 · Ages: 40 Years to 85 Years · Sex: All (male and female) · Alabama: Birmingham
• A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
  NCT07082738 · Phase: Phase 2 · Ages: 40 Years and older · Sex: All (male and female) · Alabama: Birmingham
• A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
  NCT06883305 · Phase: Phase 3 · Ages: 40 Years to 80 Years · Sex: All (male and female) · Alabama: Foley, Mobile, Sheffield
• A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
  NCT06878261 · Phase: Phase 3 · Ages: 40 Years to 80 Years · Sex: All (male and female) · Alabama: Cullman
• A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
  NCT07363694 · Phase: Phase 2, Phase 3 · Ages: 35 Years to 80 Years · Sex: All (male and female) · Alabama: Birmingham, Dothan, Mobile
• A Study to Test the Safety and Effects of Inhaled GDC-6988 in Participants With Muco-obstructive Disease
  NCT06603246 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · Alabama: Birmingham, Vestavia Hills
• Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
  NCT06891755 · Phase: Not applicable (e.g. observational or device study) · Ages: 40 Years to 84 Years · Sex: All (male and female) · Alabama: Birmingham
• Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
  NCT07059091 · Phase: Phase 2 · Ages: 40 Years and older · Sex: All (male and female) · Alabama: Birmingham
• Closed Loop Oxygen Control in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Nasal High Flow in the Hospital
  NCT07222410 · Phase: Not applicable (e.g. observational or device study) · Ages: 22 Years and older · Sex: All (male and female) · Alabama: Birmingham
• Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
  NCT06961214 · Phase: Phase 3 · Ages: 40 Years to 80 Years · Sex: All (male and female) · Alabama: Sheffield
• Effect of Ensifentrine on Sputum Markers of Inflammation in COPD
  NCT05270525 · Phase: Phase 2 · Ages: 40 Years to 80 Years · Sex: All (male and female) · Alabama: Birmingham
• Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
  NCT07190222 · Phase: Phase 3 · Ages: 40 Years to 80 Years · Sex: All (male and female) · Alabama: Birmingham
• Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD
  NCT07051707 · Phase: Not applicable (e.g. observational or device study) · Ages: 40 Years to 80 Years · Sex: All (male and female) · Alabama: Birmingham
• Genetic Variation in IgG in Alpha 1 Antitrypsin Deficiency
  NCT07135427 · Phase: Phase 4 · Ages: 19 Years and older · Sex: All (male and female) · Alabama: Birmingham
• Improving Patient-Centered Care for Underserved Older African American Patients With Cardiovascular Comorbidities
  NCT07748858 · Phase: Not specified · Ages: 50 Years to 99 Years · Sex: All (male and female) · Alabama: Birmingham
• Multi-Center Clean Air Randomized Controlled Trial in COPD
  NCT06376994 · Phase: Phase 3 · Ages: 40 Years and older · Sex: All (male and female) · Alabama: Birmingham
• PiMZ Longitudinal Cohort (PiMZ Logic)
  NCT06505603 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Alabama: Birmingham
• SPIROMICS Study of Early COPD Progression (SOURCE)
  NCT05033990 · Phase: Not specified · Ages: 30 Years to 55 Years · Sex: All (male and female) · Alabama: Birmingham
• Trial Comparing the Safety and Efficacy of Two Different Oral VPV Doses With Placebo as Treatment for RV in Participants With COPD
  NCT07610395 · Phase: Phase 2 · Ages: 40 Years to 85 Years · Sex: All (male and female) · Alabama: Mobile
• myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home
  NCT05204888 · Phase: Not applicable (e.g. observational or device study) · Ages: 30 Years and older · Sex: All (male and female) · Alabama: Birmingham